Immunological effects of refolded human soluble BAFF synthesized in Escherichia coli on murine B lymphocytes in vitro and in vivo

Japanese Journal of Physiology

Volumn 55, Issue 4, 2005, Pages 221-227

  Cao, Meng ^a   Chen, Long ^a   Shan, Xiao Xiao ^a   Zhang, Shuang Quan ^a  

^a NANJING NORMAL UNIVERSITY   (China)

Author keywords

B lymphocyte; Differentiation; Human soluble BAFF; Immune response; Proliferation

Indexed keywords

BETA CELL ACTIVATING FACTOR; IMMUNOGLOBULIN M ANTIBODY; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; B CELL ACTIVATING FACTOR; COMPLEMENT COMPONENT C3D RECEPTOR; MEMBRANE PROTEIN; TNFSF13B PROTEIN, HUMAN; TNFSF13B PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BODY MASS; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PROTEIN FAMILY; RAT; SPLEEN; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN FOLDING;

ANIMALS; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CELL PROLIFERATION; ESCHERICHIA COLI; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MICE; PROTEIN FOLDING; RECEPTORS, COMPLEMENT 3D; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645800591     PISSN: 0021521X     EISSN: 0021521X     Source Type: Journal    
DOI: 10.2170/jjphysiol.R2130     Document Type: Article

References (24)

1. Moore PA, Belvedere O, Orr A, Pieri K, Lafleur DW, Feng P, Soppet D, Charters M, Gentz R, Parmelee D, Li Y, Galperina O, Giri J, Roschke V, Nardelli B, Carrell J, Sosnovtseva S, Greenfield W, Ruben SM, Olsen HS, Fikes J, and Hilbert DM: Blys: Member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285: 260-263, 1999
2. 2-terminal kinase. J Biol Chem 274: 15978-15981, 1999
3. Schneider P, Mackay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C, Lawton P, Bixler S, Acha-Orbea H, Valmori D, Romero P, Werner-Favre C, Zubler RH, Browning JL, and Tschopp J: BAFF, a novel ligand of the tumor necrosisfactor (TNF) family, stimulates B cell growth. J Exp Med 189: 1747-1756, 1999
4. Shu HB, Hu WH, and Johnson H: TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol 65: 680-683, 1999
5. Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, Tschopp J, and Browning JL: Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190: 1697-1710, 1999
6. Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu W, Parrish-Novak J, Foster D, Lofton-Day C, Moore M, Littau A, Grossman A, Haugen H, Foley K, Blumberg H, Harrison K, Kindsvogel W, and Clegg CH: TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404: 995-999, 2000
7. Khare SD, Sarosi I, Xia XZ, McCabe S, Miner K, Solovyev I, Hawkins N, Kelley M, Chang D, Van G, Ross L, Delaney J, Wang L, Lacey D, Boyle WJ, and Hsu H: Severe B lymphocyte hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci USA 97: 3370-3375, 2000
8. Parry TJ, Riccobene TA, Strawn SJ, Williams R, Daoud R, Carrell J, Sosnovtseva S, Miceli RC, Poortman CM, Sekut L, Li Y, Fikes J, and Sung C: Pharmacokinetics and immunological effects of exogenously administered recombinant human B lymphocyte stimulator (BLyS) in mice. J Pharmacol Exp Ther 296: 396-404, 2001
9. Stewart DM, McAvoy MJ, Hilbert DM, and Nelson DL: B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro. Clin Immunol 109: 137-143, 2003
10. Carsetti R, Rosado MM, and Wardemann H: Peripheral development of B cells in mouse and man. Immunol Rev 197: 179-191, 2004
11. Cao P, Mei JJ, Diao ZY, and Zhang SQ: Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli Protein Expr Purif 41: 199-206, 2005
12. Shan X, Chen L, Cao M, Xu L, and Zhang S: Effects of human soluble BAFF synthesized in Escherichia coli on CD4+ and CD8+ T lymphocytes as well as NK cells in mice. Physiol Res 55: in press, 2006 (prepressed in http://www.biomed.cas.cz/physiolres/prepress.htm)
13. Baker KP: BLyS - an essential survival factor for B cells: basic biology, links to pathology and therapeutic target. Autoimmun Rev 3: 368-375, 2004
14. Liu Y, Hong X, Kappler J, Jiang L, Zhang R, Xu L, Pan CH, Martin WE, Murphy RC, Shu HB, Dai S, and Zhang G: Ligand-receptor binding revealed by the TNF family member TALL-1. Nature 423: 49-56, 2003
15. Rahman ZS, Rao SP, Kalled SL, and Manser T: Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice. J Exp Med 198: 1157-1169, 2003
16. Thompson JS, Schneider P, Kalled SL, Wang L, Lefevre EA, Cachero TG, MacKay F, Bixler SA, Zafari M, Liu ZY, Woodcock SA, Qian F, Batten M, Madry C, Richard Y, Benjamin CD, Browning JL, Tsapis A, Tschopp J, and Ambrose C: BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J Exp Med 192: 129-135, 2000
17. Harless SS and Cancro MP: Integrating B cell homeostasis and selection with BAFF. Arch. Immunol Ther Exp 51: 209-218, 2003
18. Oliver AM, Martin F, and Kearney JF: IgMhigh CD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B lymphocytes. J Immunol 162: 7198-7207, 1999
19. Shahaf G, Allman D, Cancro MP, and Mehr R: Screening of alternative models for transitional B cell maturation. Int Immunol 16: 1081-1090, 2004
20. Loder F, Mutschler B, Ray RJ, Paige CJ, Sideras P, Torres R, Lamers MC, and Carsetti R: B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med 190: 75-89, 1999
21. Batten M, Groom J, Cachero TG, Qian F, Schneider P, Tschopp J, Browning JL, and Mackay F: BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192: 1453-1465, 2000
22. Rolink AG, Tschopp J, Schneider P, and Melchers F: BAFF is a survival and maturation factor for mouse B cells. J Immunol 32: 2004-2010, 2002
23. Do RK, and Chen-Kiang S: Mechanism of BLyS action in B lymphocyte immunity. Cytokine Growth Factor Rev 13: 19-25, 2002
24. Batten M, Fletcher C, Ng LG, Groom J, Wheway J, Laabi Y, Xin X, Schneider P, Tschopp J, Mackay CR, and Mackay F: TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma. J Immunol 172: 812-822, 2004